Moreover, Underly et al.(39) showed that coinjection of pericyte somata and a MMP-9 inhibitor, but not a MMP-2 inhibitor, was able to reduce BBB damage during cerebral ischemia. The gene discussed is MMP9; the disease is brain ischemia.